Registration is now open for the American Society for Dermatologic Surgery (ASDS)'s first hybrid annual meeting featuring two meeting experiences: in-person October 14-17 in Chicago, and virtually November 19-21.
Accepted abstracts and posters provide key updates on Xeomin (incobotulinumtoxinA) and Radiesse.
Findings suggest that tools designed to elicit patient values can improve communication and support African American women in choosing between implant-based and autologous reconstruction after mastectomy.
